Metformina: ¿Debería ser la primera opción terapéutica en el paciente con diabetes de alto riesgo? / Should it be the first therapeutic option in the patient with high-risk diabetes?
Rev. argent. cardiol
;
89(1): 59-66, mar. 2021. tab
Article
in Spanish
|
LILACS-Express
| LILACS
| ID: biblio-1279723
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Etiology study
/
Risk factors
Language:
Spanish
Journal:
Rev. argent. cardiol
Journal subject:
Cardiology
/
Doenas Cardiovasculares
Year:
2021
Type:
Article
Affiliation country:
Argentina
Similar
MEDLINE
...
LILACS
LIS